A BRCA1 deficient, NFKB driven immune signal predicts good outcome in triple negative breast cancer

被引：0
|
作者：
Buckley, Niamh E.
Haddock, Paula
Simoes, Ricardo De Matos
Parkes, Eileen
Irwin, Gareth
Emmert-Streib, Frank
McQuaid, Stephen
Kennedy, Richard D.
Mullan, Paul B.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2270
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer
    Buckley, Niamh E.
    Haddock, Paula
    Simoes, Ricardo De Matos
    Parkes, Eileen
    Irwin, Gareth
    Emmert-Streib, Frank
    McQuaid, Stephen
    Kennedy, Richard
    Mullan, Paul
    ONCOTARGET, 2016, 7 (15) : 19884 - 19896
  • [2] Clinical Outcome of Triple Negative Breast Cancer in BRCA1 Mutation Carriers and Noncarriers
    Lee, Larissa J.
    Alexander, Brian
    Schnitt, Stuart J.
    Comander, Amy
    Gallagher, Bridget
    Garber, Judy E.
    Tung, Nadine
    CANCER, 2011, 117 (14) : 3093 - 3100
  • [3] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [4] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [5] Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
    Xu, Y.
    Diao, L.
    Chen, Y.
    Liu, Y.
    Wang, C.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Deng, D.
    Narod, S. A.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1498 - 1505
  • [6] BRCA1 promoter hypermethylation, but not BRCA1 expression, is associated with basal-like features and good prognosis in triple negative breast cancer
    Jacot, W.
    Simony-Lafontaine, J.
    Mollevi, C.
    Boissierre, F.
    Lopez-Crapez, E.
    Chartron, E.
    Lamy, P-J
    Guiu, S.
    CANCER RESEARCH, 2017, 77
  • [7] BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
    Jacot, William
    Lopez-Crapez, Evelyne
    Mollevi, Caroline
    Boissiere-Michot, Florence
    Simony-Lafontaine, Joelle
    Ho-Pun-Cheung, Alexandre
    Chartron, Elodie
    Theillet, Charles
    Lemoine, Antoinette
    Saffroy, Raphael
    Lamy, Pierre-Jean
    Guiu, Severine
    CANCERS, 2020, 12 (04)
  • [8] Evaluation of BRCA1 mutations in patients with triple negative breast cancer
    Ellsworth, Rachel E.
    Rummel, Seth
    Varner, Erika
    Shriver, Craig D.
    CANCER RESEARCH, 2012, 72
  • [9] BRCA1 mutation in the Triple- Negative Breast Cancer Group
    Jelena Maksimenko
    Arvids Irmejs
    Genadijs Trofimovics
    Edvins Miklasevics
    Hereditary Cancer in Clinical Practice, 10 (Suppl 4)
  • [10] Prevalence of BRCA1 mutations in triple negative breast cancer (BC).
    Kandel, M. J.
    Stadler, Z.
    Masciari, S.
    Collins, L.
    Schnitt, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 5S - 5S
12345